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INTRODUCTION 
In Korea, rapid socioeconomic growth has led to a more
sedentary lifestyle and change in diet over the past several
decades. As a result of prosperity, obesity has become an im-
portant health problem, as in some Western countries. While
the prevalence of obesity in Asian populations is lower than
that of Caucasian societies, the health risks associated with
obesity have been reported to occur at a lower body mass
index (BMI) (1).
Many studies have demonstrated a close relationship bet-
ween body fat distribution and the occurrence of the meta-
bolic syndrome; an excess of abdominal adipose tissue, espe-
cially intra-abdominal visceral fat, leads to obesity-related
complications (2, 3). The area of visceral fat area is most accu-
rately measured using computed tomography (CT). It is not
practical, however, to measure the visceral fat area with CT
in the clinic. Therefore, waist circumference (WC) is used as
the best simple anthropometric index of abdominal visceral
fat accumulation; these measures are related to cardiovascu-
lar risk in men and women (4, 5). 
The Third Report of the National Cholesterol Education
Program Adult Treatment Panel III (NCEP ATP III) dis-
cussed the importance of the metabolic syndrome, includ-
ing waist circumference, as diagnostic criteria, in 2001 (6).
However, the criteria were developed based on Western pati-
ents, therefore, generalization to Asian patients requires mod-
ification. In 2000, the WHO Asia-Pacific Region recom-
mended abdominal obesity diagnostic criteria for Asian pop-
ulations. Currently, NCEP ATP III criteria modified with
the WHO Asia-Pacific Region waist circumference criteria
are broadly utilized as diagnostic criteria for the metabolic
syndrome in Korea. 
However, among Asians, each ethnic group has their own
anthropometric characteristics. Therefore, it is difficult to
apply the same criteria to each of the different ethnic groups.
Determination of accurate criteria for the diagnosis of ‘obesity
related disease’ in Korean subjects is an urgent priority. Thus,
the aim of this study was to determine the appropriate cut-
off values, for visceral fat area and WC, that are associated
with an increased risk for obesity-related disorder, and to vali-
date diagnostic criteria for abdominal obesity and the meta-
bolic syndrome in an adult Korean population. 
MATERIALS AND METHODS 
Subjects 
Our study included 413 Koreans aged 18-70 yr (174 men
and 239 women) who visited the obesity clinic at St. Mary’s
Hospital and Kangnam St. Mary’s Hospital from January 1999
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Cut-off Values of Visceral Fat Area and Waist Circumference: 
Diagnostic Criteria for Abdominal Obesity in a Korean Population 
The aim of this study was to determine the appropriate cut-off values for visceral
fat area and waist circumference (WC) associated with an increase in risk for obe-
sity-related disorder, and to validate diagnostic criteria for abdominal obesity and
the metabolic syndrome in a Korean adult population. We included 413 subjects
(174 men and 239 women) for this study. Subjects were selected among Korean
adults who visited the obesity clinic at St. Mary’s Hospital and Kangnam St. Mary’s
Hospital from January 1999 to August 2005. All patients had computed tomography
performed. The cut-off value, of visceral fat area associated with an increase risk
of obesity-related disorder, according to the receiver operating characteristics curve,
was 103.8 cm
2 (sensitivity 74.5%, specificity 64.7%, p<0.001). The cut-off value for
the WC was 89.8 cm in men (sensitivity 84.7%, specificity 91.7%, p<0.005) and
86.1 cm in women (sensitivity 83.9%, specificity 62.9%, p<0.001). Based on the
results of this study, the visceral fat area associated with an increased risk of obe-
sity-related disorder in Korea was 103.8 cm
2 and the WC was 89.8 cm in men and
86.1 cm in women. 
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to August 2005. All subjects had performed a CT. All partici-
pants provided informed consent. This study was approved by
the institutional review board of the St. Mary’s Hospital and
Kangnam St. Mary’s Hospital. Excluded from this study were
individuals with an identified secondary cause of obesity, preg-
nant or lactating women and patients with evidence of severe
hepatic or renal disease. All individuals were evaluated by a phy-
sician, including a medical history and physical examination.
Anthropometric measurements
Anthropometric measurements were taken with subjects
in light clothing and without shoes. Height and weight were
measured using an automatic height-weight scale, to the near-
est 0.1 cm and 0.1 kg. BMI was calculated by dividing weight
(kg) by height2 (m2). 
Waist and hip circumference were measured with a non-
elastic tape measure. WC was measured at the end of normal
expiration, at the midpoint between the lower border of the
rib cage and the iliac crest. For the hip circumference, the tape
was positioned around the hips at the level of the symphysis
pubis and the greatest gluteal protuberance. Body fat percent
was measured by bioimpedence analysis (Inbody 2.0, Bios-
pace, Seoul, Korea); same equipment was used in both par-
ticipating hospitals. Technicians were educated to provide
precise anthropometric measurements according to guide-
lines used to reduce interpersonal variation. 
Visceral and subcutaneous fat area 
Cross-sectional abdominal visceral and subcutaneous fat
areas were measured by computed tomography (Somatom
plus, Siemens, Germany) using an established protocol (7).
The same protocol was used at both participating hospitals.
A cross-sectional scan at 10 mm thickness centered at the
L4-L5 vertebral disc space, with the subject in the supine
position, was obtained using a radiograph of the skeleton as
a reference to establish the position of the scans to the near-
est millimeter. Subcutaneous and visceral fat area (SFA and
VFA) boundaries were defined using a manual cursor by de-
lineating these areas with a graph pen. The adipose tissue
areas were calculated by computing the fat area surfaces with
an attenuation range of -190 to -30 Hounsfield units. The
abdominal VFA was measured by drawing a line in the mus-
cle wall surrounding the abdominal cavity. The SFA was cal-
culated by subtracting the VFA from the total fat area (TFA).
Then the VFA to SFA ratio (VSR) was calculated. 
Metabolic variables 
Blood pressure was measured with a mercury sphygmoma-
nometer after 10 min of rest in the sitting position. Study
subjects refrained from smoking or ingesting caffeine during
the 30 min preceding the measurement. Cuff size was select-
ed according to the arm circumference of the participants.
The first appearance of sound (phase 1 Korotkoff sound) was
used to define systolic blood pressure and the disappearance
of sound (phase 5 Korotkoff sound) to define diastolic blood
pressure (8). Two readings each for the systolic and diastolic
blood pressure were recorded, and the average of each mea-
surement was used in the final analysis. If the first two mea-
surements were different by more than 5 mmHg, addition-
al readings were obtained. 
Blood samples were obtained in the morning after 12 hr
of overnight fasting from an antecubital vein, and stored in
vacutainer tubes containing EDTA and subsequently analyzed
at a central laboratory. Fasting plasma glucose (FPG) was
measured by the glucose oxidase method, and the total choles-
terol (TC) and triglyceride (TG) levels by enzymatic proce-
dures using an autoanalyzer (Hitachi 736-20, 7170 auto-
matic analyzer, Tokyo, Japan). The high density lipoprotein
(HDL) fraction was obtained after precipitation of apo-B con-
taining lipoproteins with MnCl2. 
Obesity-related disorders 
Three obesity-related disorders were defined: hypertension
was defined by use of antihypertensive medication or a sys-
tolic blood pressure ≥140 mmHg or a diastolic blood pres-
sure ≥90 mmHg; hyperglycemia, was defined by use of
antidiabetic medication or a FPG ≥110 mg/dL; and dys-
lipidemia, was defined by a TC ≥220 mg/dL or TG ≥150
mg/dL or HDL <40 mg/dL) (9). 
Criteria for the metabolic syndrome 
The metabolic syndrome was defined according to the 2001
NCEP ATP III (6), except for abdominal obesity determined
by WC measurements which was not applicable to relatively
lean Asians. According to the Asia-Pacific regional guide-
lines, abdominal obesity was defined as a WC >90 cm for
men and >80 cm for women (1). The presence of the meta-
bolic syndrome was determined by ≥3 of the following 5
parameters in patients: a WC >90 cm for men or >80 cm
for women, serum triglyceride levels ≥150 mg/dL, serum
HDL cholesterol levels <40 mg/dL for men or <50 mg/dL
for women, systolic blood pressure ≥130 mmHg or dias-
tolic blood pressure ≥85 mmHg, and a fasting blood glu-
cose ≥110 mg/dL. 
In addition, individuals who reported currently using anti-
hypertensive or antidiabetic medication were categorized as
meeting the high blood pressure or glucose criteria, respec-
tively. 
Statistical analysis 
The statistical analysis was performed using SPSS for Win-
dows version 10.0 (SPSS Inc., Chicago, IL, U.S.A.). Data were1050 J.A. Kim, C.J. Choi, K.S. Yum
expressed using gender-specific mean values and standard
deviations for continuous variables. We used the independent
sample t-test to examine the gender difference of continuous
variables. The chi-square test was used to examine significance
according to sex. Frequency of obesity-related disorder to
BMI and VFA were calculated. In this study, high VFA was
defined as more than 100 cm2 according to the Japanese vis-
ceral obesity criteria (9). The odds ratio for the metabolic syn-
drome according to VFA was calculated. To determine the
cut-off values for VFA and WC, we examined the number
of associated clinical diagnoses (ie, hypertension, hyperglyce-
mia and dyslipidemia) at each VFA or WC level. The cut-off
values of the VFA and WC associated with an increase in the
prevalence of the obesity-related disorder was calculated using
the receiver operating characteristics (ROC) curve. Next the
sensitivity and specificity of each cut-off was estimated by
identifying subjects with more than one clinical diagnosis.
The cut-off value associated with the best combination of
sensitivity and specificity was selected as the optimal thresh-
old for each parameter. 
A value of p<0.05 was considered to be statistically signifi-
cant. 
RESULTS 
Characteristics of subjects 
Characteristics of study subjects by gender are presented
in Table 1. Of a total of 413 individuals, men (n=174) acco-
unted for 42% of the subjects and women (n=239) did 58%.
The mean BMI was 30.9±5.2 kg/m2 in men, and 29.9±
5.7 kg/m2 in women. There was no significant difference
between genders for BMI, waist/hip circumference ratio, total
cholesterol and total abdominal fat area. However, the mean
body fat was higher in women (38.5±7.0%) than in men
(31.2±6.9%). Although the total area of abdominal fat was
not significantly different, the VFA was higher for men (159.8
±73.7 cm2) than women (127.4±58.7 cm2), and the sub-
cutaneous fat area was higher in women (299.5±137.9 cm2)
than in men (234.3±125.3 cm2). Therefore the VSR was
higher for men (0.68±0.47) than for women (0.43±0.30)
(p<0.001). 
Prevalence of obesity-related disorder 
For the prevalence of obesity-related disorders, hyperten-
sion was identified in 44.6% (n=184), hyperglycemia was
27.4% (n=113) and dyslipidemia was 58.1% (n=240) of
participating subjects. The percentage of subjects, and the
frequency of the 3 obesity-related disorders, in 4 subgroups
determined by BMI (obese: BMI ≥25 kg/m2 and non-obese:
BMI <25 kg/m2) and VFA (high VFA: VFA ≥100 cm2 and
normal VFA <100 cm2) in consecutive subjects (167 men,
235 women) who underwent anthropometric measurements
are shown in Table 2. The percentage of subjects who had
no obesity-related disorder was significantly lower 16.7% (n=
67), compared to one obesity-related disorder 42.0% (n=
169) and two or more obesity-related disorders 41.3% (n=
Men (n=174)
Mean±SD Range
Women (n=239)
Mean±SD Range
Age (yr) 41.3±11.6 18.0-70.0 43.2±13.1 19.0-69.0
Height (cm)* 171.4±6.0 150.0-185.6 158.4±5.8 138.4-173.0
Weight (kg)* 91.0±16.8 58.0-151.0 75.3±16.3 43.0-124.3
Body mass  30.9±5.2 21.1-47.5 29.9±5.7 17.7-51.7
index (kg/m
2)
Body fat (%)* 31.2±6.9 14.9-48.5 38.5±7.0 17.7-57.0
Waist circum- 101.9±13.0 74.0-139.0 96.4±13.3 67.0-139.0
ference (cm)*
Hip circumfe-  109.7±11.9 91.0-143.0 105.7±13.2 81.5-143.0
rence (cm)
Waist/hip ratio 0.93±0.07 0.81-1.23 0.91±0.08 0.8-1.3
Systolic BP 134.4±16.4 100.0-192.0 128.0±17.1 80.0-213.0
(mmHg)*
Diastolic BP  87.6±11.9 57.0-131.0 81.6±11.9 56.0-130.0
(mmHg)*
Fasting glu- 109.8±24.6 78.0-250.0 105.2±27.5 68.0-296.0
cose (mg/dL)*
Total choles-  199.0±36.5 104.0-288.0 203.6±40.9 121.0-459.0
terol (mg/dL)
Triglyceride 184.5±103.5 44.0-578.0 133.2±102.7 32.0-744.0
(mg/dL)*
HDL (mg/dL)* 42.2±8.9 25.0-70.0 47.2±12.3 25.0-94.0
Abdominal fat area (cm
2)
Total 394.1±162.7 66.9-953.1 426.8±169.3 100.3-1060.2 
Visceral* 159.8±73.7 17.6-691.5 127.4±58.7 41.3-519.2
Subcuta- 234.3±125.3 28.4-608.6 299.5±137.9 49.5-709.3
neous*
VSR* 0.68±0.47 0.07-2.64 0.43±0.30 0.13-2.50
Table 1. General characteristics of the study subjects 
SD, Standard deviation; VSR, Visceral fat area/subcutaneous fat area
ratio. *p<0.05: by independent samples t-test.
Non-obese subjects
(BMI <25 kg/m
2)
Normal 
VFA
High
VFA
Obese subjects
(BMI ≥25 kg/m
2)
Normal 
VFA
High
VFA
Total
No  disorder (%) 18  8  22  19  67 
(43.9%) (30.8%) (27.2%) (7.5%) (16.7%)
Single disorder (%)  20  12 36 101  169 
(48.8%) (46.2%) (44.4%) (39.8%) (42.0%)
Two or more 3 6 23 134 166
disorders (%) (7.3%) (23.0%)* (28.4%)* (52.7%)
� ,� (41.3%)
Table 2. Frequency of obesity-related disorders in non-obese
and obese subjects with normal and high visceral fat area (VFA)
Normal VFA, visceral fat area <100 cm
2; High VFA, visceral fat area ≥100
cm
2; Disorders, hyperglycemia, dyslipidemia and hypertension are de-
fined in methods.
p-values: by chi-square test and adjusted by Bonferroni method. *p<
0.05 and 
� p<0.005 vs. non-obese subjects with normal VFA, 
� p<0.001
vs. obese subjects with normal VFA. Criteria for Abdominal Obesity 1051
166). Consequently, the proportion of subjects with multi-
ple risk factors was significantly higher in obese subjects with
a high VFA. However, the proportion of non-obese subjects
with a high VFA, and obese subjects with normal VFA was
similar (Table 2). 
Cut-off values for visceral fat area and waist circumference
associated with increase in the prevalence of the obesity-
related disorders
The cut-off value for VFA using the ROC curve was 103.8
cm2 (sensitivity 74.5%, specificity 64.7%, p<0.001). Using
the same method, the cut-off value for WC was 89.8 cm for
men (sensitivity 84.7%, specificity 91.7%, p<0.005) and
86.1 cm for women (sensitivity 83.6%, specificity 62.9%,
p<0.001) (Fig. 1, 2). 
Prevalence of metabolic syndrome
The prevalence of the metabolic syndrome was 52.8% (n=
218); men accounted for 62.1% (n=108) and women 46.0%
(n=110). The odds ratios for the metabolic syndrome based
on an increase in visceral fat compared to those within the
reference range (VFA<100 cm2) were obtained. Each odds
ratio showed a tendency to increase with VFA statistically
(p<0.001) (Table 3). 
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Fig. 1. ROC (receiver-operating characteristics) curve for cut-off
value of visceral fat area (VFA) to increase the obesity-related dis-
order. Area under the curve=0.741, p<0.001. Sensitivity and spe-
cificity at a WC of 103.8 cm
2 were 74.5% and 64.7%. 
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Fig. 2. ROC (receiver-operating characteristics) curves for cut-off value of waist circumference (WC) associated with increase in obesity-
related disorder. (A) In men: Area under the curve=0.911, p<0.005. Sensitivity and specificity at a WC of 89.8 cm were 84.7% and 91.7%.
(B) In women: Area under the curve=0.739, p<0.001. Sensitivity and specificity at a WC of 86.1 cm were 83.6% and 62.9%.
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B
VFA (cm
2) MS (%)
Crude OR 
(95% CI)
Adjusted OR 
(95% CI)
p-
value
p-
value
VFA <100 28.5 1 1
100≤ VFA <150 54.1 2.96 <0.001 2.75 <0.001
(1.76-4.97) (1.62-4.68)
150≤ VFA <200 67.7 5.28 <0.00 14.65 <0.001
(2.94-9.48) (2.53-4.68)
200≤ VFA <250 73.8 7.09 <0.001 6.07 <0.001
(3.21-15.64) (2.68-4.68)
250≤ VFA 80 10.06 <0.001 8.08 <0.001
(3.14-32.20) (2.46-4.68)
Table 3. Prevalence and odds ratios (OR) for the metabolic syn-
drome according to visceral fat area (VFA)
VFA, visceral fat area <100 cm
2; MS, metabolic syndrome; CI, confidence
interval. p-values: by multiple logistic regression analysis adjusted for age,
sex.1052 J.A. Kim, C.J. Choi, K.S. Yum
DISCUSSION 
An increased waist circumference has been demonstrated
to be a good predictor of cardiovascular disease (5), and is an
important diagnostic marker for the metabolic syndrome.
Although CT scanning and magnetic resonance imaging are
used for precise measurements of visceral fat (10, 11), simple
anthropometric measurements for estimating the amount of
visceral fat are essential for practical screening of the general
population. On the basis of prior studies, the WC has been
shown to directly reflect abdominal fat mass (12, 13).
WHO initially proposed a definition for metabolic syn-
drome in 1998 (14). The Third Report of NCEP ATP III
proposed useful criteria for the diagnosis of the metabolic
syndrome in 2001 (6). However, the measurements offered
for cut-off criteria for abdominal circumference of more than
102 cm in men and more than 88 cm in women for abdom-
inal obesity are based on Caucasian criteria. Therefore the
prevalence of the metabolic syndrome, based on these crite-
ria, in the Asian population is very low (15, 16). 
A number of studies comparing Asian ethnics, such as Fil-
ipinos (17), Japanese (18) and South Asians (19) with Cau-
casians have reported that Asians had higher risk of diabetes
and/or the metabolic syndrome even though they had lower
fat measurements. Asian populations have been shown to
have a higher body fat deposition at a lower BMI than Cau-
casians (20-22). Abdominal obesity promotes insulin resis-
tance and leads to the metabolic syndrome (23). Therefore, at
a relatively low BMI, Asians have higher glucose intolerance
(24) and cardiovascular risk factors compared to Caucasians. 
Accordingly, the criteria for obesity, as proposed by the
Asian-Pacific region of WHO, is a BMI ≥25 kg/m2 (1). The
cut-off values used for WC, to determine abdominal obesity,
are 90 cm for men and 80 cm for women in Asian popula-
tions (1). According to these criteria, Kwon et al. (25) reported
that the prevalence of the metabolic syndrome in the adult
Korean population was 34.3% (men 26.3%, women 40.1%).
Therefore, the metabolic syndrome is a serious problem in
Korean society. 
In 2002, a study on 1,193 Japanese subjects found that
the WC measurement that equated with a VFA of 100 cm2
was a useful cut-off for the prediction of patients with more
than one clinical diagnosis, i.e. dyslipidemia, hyperglycemia
and hypertension. This 100 cm2 value is exceeded by 70%
of those Japanese patients identified with coronary heart dis-
ease. Therefore, Japanese guidelines have established a cut-
off point for waist circumference to be 85 cm in men and 90
cm in women (9). 
However, in Korea, Choi et al. (26) and Park et al. (27)
reported that the cut-off point should be a WC of 90 cm in
men and 85 cm in women, and Lee et al. (28) reported that
it should be 89 cm in men and 86 cm in women. Therefore,
there remains controversy regarding the appropriate cut-off
point for the WC as a diagnosis for abdominal obesity in the
adult Korean population. 
In our study, the cut-off value for VFA, that is associated
with an increase risk for an obesity-related disorder using the
ROC curve, was 103.8 cm2 (sensitivity 74.5%, specificity
64.7%, p<0.001). This cut-off point is similar to that used
by the Japanese, 100 cm2 (13). The cut-off value for WC was
89.8 cm in men (sensitivity 84.7%, specificity 91.7%, p<
0.005) and 86.1 cm in women (sensitivity 83.6%, specifici-
ty 62.9%, p<0.001). Our study results show a higher WC
level in women than that offered by the 2000 WHO Asia-
Pacific guideline, 80 cm (1), and many other studies in Korea
agree that the cut-off value of 80 cm in Korean women is too
low (25-28). 
Our study had the following limitations. Because we rec-
ruited subjects from a specialty clinic, the findings from our
study group cannot be generalized to the general Korean pop-
ulation. In addition, we had limited information on other,
potentially important information such as smoking habits,
alcohol use and whether subjects exercised. Moreover, the
number of study subjects was small. 
Further studies are necessary to define the level of abdom-
inal obesity to predict cardiovascular risk among relatively
lean Asians, and to unravel determinants of the metabolic
syndrome for primary prevention. We would like to recom-
mend that a standard health examination include assessment
for the metabolic syndrome including abdominal obesity
measurements, and based on the results secondary preven-
tion be implemented immediately. 
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